Creve Coeur, Maryland Clinical Trials

A listing of Creve Coeur, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 64 clinical trials
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

treatment regimen
x-rays
ct scan
SARS
oxygen supplementation
The Lung Research Center (St. Luke's)
 (8.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +13 other locations
Oral EPI-7386 in Patients With Metastatic Castration-Resistant Prostate Cancer

This is a phase I, clinical research study of EPI-7386, an investigational drug being studied as a treatment for patients with prostate cancer. All patients in the study will receive EPI-7386. Since this is the first study of EPI-7386 in humans, there is no information about how it affects people …

metastatic castration-resistant prostate cancer
soft tissue disease
bone lesion
castration-resistant prostate cancer
diphosphonates
Washington University School of Medicine in St. Louis
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies

This is a Phase I dose-finding study of FT596 as monotherapy and in combination with Rituximab or Obinutuzumab in subjects with relapsed/refractory B-cell Lymphoma or Chronic Lymphocytic Leukemia. The study will consist of a dose-escalation stage and an expansion stage where participants will be enrolled into indication-specific cohorts.

rituximab fludarabine
lymphocytic leukemia
chronic lymphocytic leukemia
lymphoma
immunochemotherapy
Washington University School of Medicine
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

clinical stage ivb gastric cancer ajcc v8
lymphadenopathy
sprue
recurrent disease
cancer
Missouri Baptist Medical Center
 (2.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

solid tumor
egf receptors
epidermal growth factor receptor
venetoclax
anaplastic lymphoma
Washington University-School of Medicine /ID# 212355
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

solid tumors
melanoma
nervous system
blood count
hodgkin's disease
Washington University School of Medicine
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

crizotinib
schwartz
cataract
glioma
nf2 gene
Washington University - St. Louis (Site 900)
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +16 other locations
Multicenter Clinical Trial of a Phakic Implantable Collamer Lens (ICL)

This objective of this study is to evaluate the safety, and to collect supportive data on effectiveness of the EVO/EVO+ Visian Implantable Collamer Lens (ICL) in study participants who have a diagnosis of myopia or myopia with astigmatism. Primary study analysis will be evaluated when 300 primary eyes complete 6 …

severe myopia
myopia
astigmatism
Brinton Vision
 (3.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +13 other locations
Cost Talk: Discussing Cancer Care Costs

The purpose of this study is to investigate whether an encounter decision aid (used during a consultation) containing cost information about options, combined with clinician training about cost discussions and available financial resources, influence surgeon-patient cost conversations, referrals to address costs, patients' financial stress, and high-quality decision-making for patients with …

prostate specific antigen
cancer care
Washington University School of Medicine
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Diffusion Basis Spectrum Imaging of the Prostate

Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

prostate cancer screening
biopsy of prostate
Washington University School of Medicine
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location